InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: cjgaddy post# 2719

Monday, 08/08/2005 4:21:29 PM

Monday, August 08, 2005 4:21:29 PM

Post# of 346056
Much to our advantage are the points that:

1. Bach and Godofsky Infectious Diseases is a large clinc that is specializing in the treatment of viral hepatitis and should have all the qualified candidates already involved in their clinc and ready to go with Tarvacin.

2. Tarvacin should work very quickly. Viral counts should be available within days of infusion.

3. Safety was just not an issue with all mammals right up to primates. It is not going to be an unsafe anti-body for we primates either.

4. NIAID screens are all well advanced. There could be a press release from there anytime now.

5. USAMRIID would not have been so interested if Tarvacin had not been working well in the NIAID screens.

6. This multiple process around Tarvacin at this geopolitical time could yield the fastest drug approval ever. This really should be as big as antibiotics were for medical history.

"You are there"
sunstar


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News